IV Equipment Market Size, Share, Growth, and Regional Forecast, 2026 - 2033

IV Equipment Market Share and Trends Analysis

The global IV equipment market size is estimated to grow from US$15.8 billion in 2026 and projected to reach US$22.3 billion by 2033, growing at a CAGR of 5.1% during the forecast period from 2026 to 2033. The global market is driven by rising hospitalizations, chronic disease prevalence, and expanding home healthcare services. Key products include IV catheters, infusion sets, and administration sets, catering to both acute and long-term care.

Technological advancements, such as safety-engineered devices and smart infusion pumps, are enhancing patient safety and treatment efficiency. Growing awareness of infection control and the shift toward minimally invasive procedures further fuel demand. North America and Europe lead in market share, while Asia-Pacific emerges as a fast-growing region due to rising healthcare infrastructure investments and increasing patient populations.

Key Industry Highlights

• The IV equipment market is expanding steadily due to increasing chronic disease incidence, aging populations, and rising surgical procedures.
• Innovation is transforming the market, with smart infusion pumps, safety-engineered catheters, and closed system transfer devices improving accuracy and reducing infection risks.
• North America holds the largest share due to advanced healthcare infrastructure and regulatory compliance.
• Asia-Pacific is the fastest-growing region, fueled by rising healthcare expenditure, increasing hospital networks, and a growing population with chronic diseases, offering significant expansion potential for global IV equipment providers.
• Leading Segment: IV catheters are used for almost every intravenous therapy, from fluids, medications, blood transfusions, to nutrition.

Key Insights	Details
IV Equipment Market Size (2026E)	US$15.8 Bn
Market Value Forecast (2033F)	US$22.3 Bn
Projected Growth (CAGR 2026 to 2033)	5.1%
Historical Market Growth (CAGR 2020 to 2024)	4.8%

Market Dynamics

Driver - Advancements in Safety-Engineered Devices

Advancements in safety-engineered IV devices are transforming intravenous therapy by significantly enhancing patient safety and clinical efficiency. Innovations such as needleless connectors reduce the risk of needlestick injuries and cross-contamination, while anti-reflux catheters prevent backflow, minimizing infection and fluid leakage. Meanwhile, smart infusion pumps offer precise dosing, automated alerts, and integration with hospital IT systems, allowing real-time monitoring of therapy and reducing medication errors. These technologies not only improve patient outcomes but also increase clinician confidence, driving widespread adoption in hospitals, outpatient centers, and home-care settings. The growing emphasis on safety and regulatory compliance fuels this trend.

Restraints - Risk of Device-Related Infections

IV equipment, while essential for delivering fluids and medications, carries inherent risks of device-related infections. Even with advances in sterilization and safety-engineered designs, improper handling, prolonged catheter use, or lapses in aseptic technique can lead to bloodstream infections (BSIs) in patients. Such infections not only prolong hospital stays but also increase morbidity, mortality, and treatment costs. Hospitals face heightened liability and reputational risks if infection control protocols are inadequate. Consequently, healthcare providers must invest in staff training, strict adherence to hygiene standards, and regular monitoring to minimize infection risks and ensure patient safety.

Opportunity - Needle-Free & Safety Devices

The demand for needle-free and safety IV devices is accelerating as healthcare facilities prioritize patient and staff safety. Needleless connectors and safety-engineered catheters minimize the risk of needlestick injuries, which are a major concern for nurses and clinicians, while also preventing cross-contamination and hospital-acquired infections. These devices offer secure, closed-system designs that simplify IV access, reduce handling errors, and enhance workflow efficiency. With growing awareness of infection control and stringent regulatory standards globally, hospitals are increasingly adopting these innovative solutions. The trend is further fueled by the expansion of high-volume infusion therapies in both acute care and home healthcare settings.

Category-wise Analysis

By Product Type Insights

IV catheters are the leading segment in the IV equipment market due to their essential role in almost all intravenous therapies, from fluid administration to medications and blood transfusions. Their high-volume, disposable nature ensures frequent replacement, driving continuous demand across hospitals, clinics, and home-care settings. Catheters are relatively affordable and widely accessible, allowing penetration in both developed and emerging markets. Innovations like needleless and safety-engineered catheters enhance patient safety, reduce needlestick injuries, and prevent infections, further increasing adoption. Combined with regulatory emphasis on infection control and the growing prevalence of chronic and acute diseases, IV catheters remain indispensable and market-leading.

By End-user Insights

Hospitals account for the highest share of the IV equipment market because they manage the largest volume of patients requiring intravenous therapy, including critical care, surgeries, emergency treatments, and chronic disease management. They utilize a wide range of IV devices-catheters, infusion pumps, administration sets, and safety devices daily, creating continuous demand. Hospitals also follow strict infection control and safety regulations, encouraging adoption of high-quality and innovative IV equipment. Compared to clinics, home care, and ambulatory centers, hospitals handle more complex procedures and higher patient turnover, making them the primary and most consistent end-users in the IV equipment market.

Region-wise Insights

North America IV Equipment Market Trends

North America leads the IV equipment market, driven by advanced healthcare infrastructure, high hospital density, and strict regulatory standards. The U.S. dominates regional demand, fueled by increasing chronic disease prevalence, aging populations, and rising surgical procedures. Adoption of smart infusion pumps, safety-engineered catheters, and needleless connectors is widespread, enhancing patient safety and workflow efficiency. Strong reimbursement policies, well-established supply chains, and emphasis on infection control further accelerate growth. Additionally, the rise of home healthcare services and outpatient infusion therapies in the U.S. is expanding the market beyond hospitals, reinforcing North America’s leadership and setting benchmarks for global IV equipment adoption.

Asia Pacific IV Equipment Market Trends

Asia-Pacific is emerging as a high-growth region in the IV equipment market, driven by expanding healthcare infrastructure, increasing hospital construction, and rising prevalence of chronic and acute diseases. Countries such as China, India, and Japan are witnessing growing demand for IV catheters, infusion pumps, and administration sets due to increasing surgical procedures and outpatient care services. Affordable and cost-effective IV solutions are gaining traction in emerging economies, while rising awareness of infection control and safety devices fuels adoption. Government initiatives, healthcare modernization, and expanding home care services further strengthen market growth, positioning Asia-Pacific as a key opportunity hub for global IV equipment manufacturers.

Market Competitive Landscape

The global IV equipment market is highly competitive, driven by innovation, product quality, and geographic expansion. Companies focus on developing advanced solutions such as smart infusion pumps, safety-engineered catheters, and needleless connectors to enhance patient safety and workflow efficiency. Key strategies include R&D investment, strategic partnerships, and technological upgrades to differentiate offerings. Market players also compete on pricing, regulatory compliance, and service quality to capture diverse healthcare segments.

Key Industry Developments:  

• In January 2025, BD invested in its U.S. manufacturing network to expand capacity for critical medical devices, including syringes, needles, and IV catheters, to meet the ongoing needs of the nation’s healthcare system.

Companies Covered in IV Equipment Market

• Becton, Dickinson and Company
• B. Braun Melsungen AG
• Fresenius SE & Co. KGaA
• Baxter International Inc.
• Smiths Medical
• ICU Medical, Inc.
• C. R. Bard, Inc.
• Terumo Corporation
• Moog, Inc.
• AngioDynamics, Inc.
• Others